Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
November-2021 Volume 22 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2021 Volume 22 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Prediction of in‑hospital recurrence and false‑negative results in patients with COVID‑19 by red blood cell values on admission

  • Authors:
    • Xue Jiang
    • Yan Hu
    • Xiao-Peng Qu
    • Dong-Wei Xu
    • Hong Jiang
    • Chun-Mei Li
    • Hua Jiang
    • Da-Li Wang
    • Gang Li
    • Xin-Gen Zhu
    • Bei Liu
  • View Affiliations / Copyright

    Affiliations: Third Department of Infectious Diseases, Huoshenshan Hospital, Joint Logistics Support Force of The Chinese People's Liberation Army, Wuhan, Hubei 430101, P.R. China, Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shanxi 710038, P.R. China, Department of Neurosurgery, The Second Affiliated Hospital, Nanchang University, Nanchang, Jiangxi 330008, P.R. China
    Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 1250
    |
    Published online on: September 2, 2021
       https://doi.org/10.3892/etm.2021.10685
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The clinical characteristics and risk factors of patients with coronavirus disease 2019 (COVID‑19) with re‑positive or false‑negative test results have so far remained to be determined. The present study provides a cross‑sectional observational study on 134 hospitalized patients selected from Huoshenshan Hospital (Wuhan, China) using cluster sampling. A total of 68 patients had reduced red blood cell (RBC) counts, 55 a decrease in the hemoglobin concentration (HBC) and 73 a decline in hematocrit (HCT). The false‑negative rate of severe acute respiratory syndrome coronavirus‑2 (SARS‑CoV‑2) RNA detection in pharyngeal swab specimens was 18.7%. The absolute lymphocyte count (ALC), RBC, HBC and HCT levels in false‑negative patients were significantly higher than those in patients who tested positive for viral nucleic acids. Multivariate logistic regression analysis indicated that RBC [odds ratio (OR)=0.43, 95% CI: 0.18‑0.99], HBC (OR=0.97, 95% CI: 0.94‑0.99) and ALC (OR=0.43, 95% CI: 0.20‑0.91) were the factors influencing the negative testing results for viral nucleic acid. The rate of re‑positive patients was 16.4%. The white blood cell, RBC, HBC and HCT values in re‑positive patients were lower than those in non‑re‑positive patients. The median (interquartile range) values for RBC, HBC and HCT of male re‑positive patients were 3.95 (3.37, 4.2) x1012/l, 123 (103, 133) g/l and 36.6 (31.1, 39.2)%, respectively, while the RBC, HBC and HCT of female re‑positive patients were 3.54 (3.13, 3.74) x1012/l, 115 (102, 118) g/l and 34.2 (28.5, 34.9)%, respectively. It was determined that RBC, HBC and HCT values had moderate accuracy in predicting SARS‑CoV‑2 recurrence in patients with COVID‑19 using receiver operating curve analysis. The present study suggested that RBC may have an important role in the pathogenesis of COVID‑19.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al: A Novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 382:727–733. 2020.PubMed/NCBI View Article : Google Scholar

2 

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, et al: Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 382:1199–1207. 2020.PubMed/NCBI View Article : Google Scholar

3 

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, et al: Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 382:1708–1720. 2020.PubMed/NCBI View Article : Google Scholar

4 

Lai CC, Shih TP, Ko WC, Tang HJ and Hsueh PR: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 55(105924)2020.PubMed/NCBI View Article : Google Scholar

5 

Zhao W, Zhong Z, Xie X, Yu Q and Liu J: Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) Pneumonia: A multicenter study. AJR Am J Roentgenol. 214:1072–1077. 2020.PubMed/NCBI View Article : Google Scholar

6 

Poland GA: SARS-CoV-2: A time for clear and immediate action. Lancet Infect Dis. 20:531–532. 2020.PubMed/NCBI View Article : Google Scholar

7 

Calina D, Docea AO, Petrakis D, Egorov AM, Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Carvalho F, Vinceti M, et al: Towards effective COVID19 vaccines: Updates, perspectives and challenges (Review). Int J Mol Med. 46:3–16. 2020.PubMed/NCBI View Article : Google Scholar

8 

Stancioiu F, Papadakis GZ, Kteniadakis S, Izotov BN, Coleman MD, Spandidos DA and Tsatsakis A: A dissection of SARSCoV2 with clinical implications (Review). Int J Mol Med. 46:489–508. 2020.PubMed/NCBI View Article : Google Scholar

9 

Kang YJ: South Korea's COVID-19 infection status: From the perspective of re-positive test results after viral clearance evidenced by negative test results. Disaster Med Public Health Prep. 14:762–764. 2020.PubMed/NCBI View Article : Google Scholar

10 

Simon V, van Bakel H and Sordillo EM: Positive, again! What to make of ‘re-positive’ SARS-CoV-2 molecular test results. EBioMedicine. 60(103011)2020.PubMed/NCBI View Article : Google Scholar

11 

Habibzadeh P, Sajadi MM, Emami A, Karimi MH, Yadollahie M, Kucheki M, Akbarpoor S and Habibzadeh F: Rate of re-positive RT-PCR test among patients recovered from COVID-19. Biochem Med (Zagreb). 30(030401)2020.PubMed/NCBI View Article : Google Scholar

12 

Wong J, Koh WC, Momin RN, Alikhan MF, Fadillah N and Naing L: Probable causes and risk factors for positive SARS-CoV-2 test in recovered patients: Evidence from Brunei Darussalam. J Med Virol. 92:2847–2851. 2020.PubMed/NCBI View Article : Google Scholar

13 

He S, Zhou K, Hu M, Liu C, Xie L, Sun S, Sun W and Chen L: Clinical characteristics of ‘re-positive’ discharged COVID-19 pneumonia patients in Wuhan, China. Sci Rep. 10(17365)2020.PubMed/NCBI View Article : Google Scholar

14 

Pan Y, Long L, Zhang D, Yuan T, Cui S, Yang P, Wang Q and Ren S: Potential false-negative nucleic acid testing results for severe acute respiratory syndrome coronavirus 2 from thermal inactivation of samples with low viral loads. Clin Chem. 66:794–801. 2020.PubMed/NCBI View Article : Google Scholar

15 

Wikramaratna PS, Paton RS, Ghafari M and Lourenco J: Estimating the false-negative test probability of SARS-CoV-2 by RT-PCR. Euro Surveill. 25(2000568)2020.PubMed/NCBI View Article : Google Scholar

16 

Hanson KE, Caliendo AM, Arias CA, Englund JA, Lee MJ, Loeb M, Patel R, El Alayli A, Kalot MA, Falck-Ytter Y, et al: Infectious diseases society of America guidelines on the Diagnosis of COVID-19. Clin Infect Dis. (ciaa760)2020.PubMed/NCBI View Article : Google Scholar

17 

National Health Commission of the People's Republic of China. Chinese management guideline for COVID-19 (version 7.0). http://www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf. Accessed March 3, 2020.

18 

World Health Organization: Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance. https://www.who.int/publications/i/item/10665-331501. Accessed January 17, 2020.

19 

Cunarro-Lopez Y, Cano-Valderrama O, Pintado-Recarte P, Cueto-Hernández I, González-Garzón B, García-Tizón S, Bujan J, Asúnsolo Á, Ortega MA and De León-Luis JA: Maternal and perinatal outcomes in patients with suspected COVID-19 and their relationship with a negative RT-PCR result. J Clin Med. 9(3552)2020.PubMed/NCBI View Article : Google Scholar

20 

Chen W, Lan Y, Yuan X, Deng X, Li Y, Cai X, Li L, He R, Tan Y, Deng X, et al: Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect. 9:469–473. 2020.PubMed/NCBI View Article : Google Scholar

21 

Jeong JH, Kim KH, Jeong SH, Park JW, Lee SM and Seo YH: Comparison of sputum and nasopharyngeal swabs for detection of respiratory viruses. J Med Virol. 86:2122–2127. 2014.PubMed/NCBI View Article : Google Scholar

22 

Zou X, Chen K, Zou J, Han P, Hao J and Han Z: Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 14:185–192. 2020.PubMed/NCBI View Article : Google Scholar

23 

Castells L, Vargas V, Allende H, Bilbao I, Luis Lázaro J, Margarit C, Esteban R and Guardia J: Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation. J Hepatol. 43:53–59. 2005.PubMed/NCBI View Article : Google Scholar

24 

Tame M, Buonfiglioli F, Del Gaudio M, Lisotti A, Cecinato P, Colecchia A, Azzaroli F, D'Errico A, Arena R, Calvanese C, et al: Long-term leukocyte natural alpha-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. World J Gastroenterol. 19:5278–5285. 2013.PubMed/NCBI View Article : Google Scholar

25 

Siegel I, Liu TL and Gleicher N: The red-cell immune system. Lancet. 2:556–559. 1981.PubMed/NCBI View Article : Google Scholar

26 

Morera D and MacKenzie SA: Is there a direct role for erythrocytes in the immune response? Vet Res. 42(89)2011.PubMed/NCBI View Article : Google Scholar

27 

Minasyan H: Phagocytosis and oxycytosis: Two arms of human innate immunity. Immunol Res. 66:271–280. 2018.PubMed/NCBI View Article : Google Scholar

28 

Gonzalez-Casas R, Garcia-Buey L, Jones EA, Gisbert JP and Moreno-Otero R: Systematic review: Hepatitis-associated aplastic anaemia-a syndrome associated with abnormal immunological function. Aliment Pharmacol Ther. 30:436–443. 2009.PubMed/NCBI View Article : Google Scholar

29 

Gonzalez-Casas R, Jones EA and Moreno-Otero R: Spectrum of anemia associated with chronic liver disease. World J Gastroenterol. 15:4653–4658. 2009.PubMed/NCBI View Article : Google Scholar

30 

Young NS, Calado RT and Scheinberg P: Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 108:2509–2519. 2006.PubMed/NCBI View Article : Google Scholar

31 

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, et al: Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ. 368(m1091)2020.PubMed/NCBI View Article : Google Scholar

32 

Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J, Zhao D, Xu D, Gong Q, et al: Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. Lancet. 395:809–815. 2020.PubMed/NCBI View Article : Google Scholar

33 

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395:497–506. 2020.PubMed/NCBI View Article : Google Scholar

34 

Schoch C, Blumenthal R and Clague MJ: A long-lived state for influenza virus-erythrocyte complexes committed to fusion at neutral pH. FEBS Lett. 311:221–225. 1992.PubMed/NCBI View Article : Google Scholar

35 

Skehel JJ and Wiley DC: Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu Rev Biochem. 69:531–569. 2000.PubMed/NCBI View Article : Google Scholar

36 

Beck Z, Brown BK, Wieczorek L, Peachman KK, Matyas GR, Polonis VR, Rao M and Alving CR: Human erythrocytes selectively bind and enrich infectious HIV-1 virions. PLoS One. 4(e8297)2009.PubMed/NCBI View Article : Google Scholar

37 

Davies AJ and Johnston MR: The biology of some intraerythrocytic parasites of fishes, amphibia and reptiles. Adv Parasitol. 45:1–107. 2000.PubMed/NCBI View Article : Google Scholar

38 

Wessel O, Krasnov A, Timmerhaus G, Rimstad E and Dahle MK: Antiviral responses and biological concequences of piscine orthoreovirus infection in salmonid erythrocytes. Front Immunol. 9(3182)2019.PubMed/NCBI View Article : Google Scholar

39 

Finstad OW, Dahle MK, Lindholm TH, Nyman IB, Løvoll M, Wallace C, Olsen CM, Storset AK and Rimstad E: Piscine orthoreovirus (PRV) infects Atlantic salmon erythrocytes. Vet Res. 45(35)2014.PubMed/NCBI View Article : Google Scholar

40 

Wessel O, Braaen S, Alarcon M, Haatveit H, Roos N, Markussen T, Tengs T, Dahle MK and Rimstad E: Infection with purified Piscine orthoreovirus demonstrates a causal relationship with heart and skeletal muscle inflammation in Atlantic salmon. PLoS One. 12(e0183781)2017.PubMed/NCBI View Article : Google Scholar

41 

Takano T, Nawata A, Sakai T, Matsuyama T, Ito T, Kurita J, Terashima S, Yasuike M, Nakamura Y, Fujiwara A, et al: Full-genome sequencing and confirmation of the causative agent of erythrocytic inclusion body syndrome in coho salmon identifies a new type of piscine orthoreovirus. PLoS One. 11(e0165424)2016.PubMed/NCBI View Article : Google Scholar

42 

Hauge H, Vendramin N, Taksdal T, Olsen AB, Wessel Ø, Mikkelsen SS, Alencar ALF, Olesen NJ and Dahle MK: Infection experiments with novel Piscine orthoreovirus from rainbow trout (Oncorhynchus mykiss) in salmonids. PLoS One. 12(e0180293)2017.PubMed/NCBI View Article : Google Scholar

43 

Fischer JE, Bachmann LM and Jaeschke R: A readers' guide to the interpretation of diagnostic test properties: Clinical example of sepsis. Intensive Care Med. 29:1043–1051. 2003.PubMed/NCBI View Article : Google Scholar

44 

Swets JA: Measuring the accuracy of diagnostic systems. Science. 240:1285–1293. 1988.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Jiang X, Hu Y, Qu X, Xu D, Jiang H, Li C, Jiang H, Wang D, Li G, Zhu X, Zhu X, et al: Prediction of in‑hospital recurrence and false‑negative results in patients with COVID‑19 by red blood cell values on admission. Exp Ther Med 22: 1250, 2021.
APA
Jiang, X., Hu, Y., Qu, X., Xu, D., Jiang, H., Li, C. ... Liu, B. (2021). Prediction of in‑hospital recurrence and false‑negative results in patients with COVID‑19 by red blood cell values on admission. Experimental and Therapeutic Medicine, 22, 1250. https://doi.org/10.3892/etm.2021.10685
MLA
Jiang, X., Hu, Y., Qu, X., Xu, D., Jiang, H., Li, C., Jiang, H., Wang, D., Li, G., Zhu, X., Liu, B."Prediction of in‑hospital recurrence and false‑negative results in patients with COVID‑19 by red blood cell values on admission". Experimental and Therapeutic Medicine 22.5 (2021): 1250.
Chicago
Jiang, X., Hu, Y., Qu, X., Xu, D., Jiang, H., Li, C., Jiang, H., Wang, D., Li, G., Zhu, X., Liu, B."Prediction of in‑hospital recurrence and false‑negative results in patients with COVID‑19 by red blood cell values on admission". Experimental and Therapeutic Medicine 22, no. 5 (2021): 1250. https://doi.org/10.3892/etm.2021.10685
Copy and paste a formatted citation
x
Spandidos Publications style
Jiang X, Hu Y, Qu X, Xu D, Jiang H, Li C, Jiang H, Wang D, Li G, Zhu X, Zhu X, et al: Prediction of in‑hospital recurrence and false‑negative results in patients with COVID‑19 by red blood cell values on admission. Exp Ther Med 22: 1250, 2021.
APA
Jiang, X., Hu, Y., Qu, X., Xu, D., Jiang, H., Li, C. ... Liu, B. (2021). Prediction of in‑hospital recurrence and false‑negative results in patients with COVID‑19 by red blood cell values on admission. Experimental and Therapeutic Medicine, 22, 1250. https://doi.org/10.3892/etm.2021.10685
MLA
Jiang, X., Hu, Y., Qu, X., Xu, D., Jiang, H., Li, C., Jiang, H., Wang, D., Li, G., Zhu, X., Liu, B."Prediction of in‑hospital recurrence and false‑negative results in patients with COVID‑19 by red blood cell values on admission". Experimental and Therapeutic Medicine 22.5 (2021): 1250.
Chicago
Jiang, X., Hu, Y., Qu, X., Xu, D., Jiang, H., Li, C., Jiang, H., Wang, D., Li, G., Zhu, X., Liu, B."Prediction of in‑hospital recurrence and false‑negative results in patients with COVID‑19 by red blood cell values on admission". Experimental and Therapeutic Medicine 22, no. 5 (2021): 1250. https://doi.org/10.3892/etm.2021.10685
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team